GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $210,000 | +44.8% | 17,496 | +0.7% | 0.08% | +55.6% |
| Q2 2022 | $145,000 | +10.7% | 17,370 | +15.5% | 0.05% | -8.5% |
| Q1 2022 | $131,000 | -27.2% | 15,039 | -5.6% | 0.06% | -13.2% |
| Q4 2021 | $180,000 | -40.6% | 15,932 | -33.9% | 0.07% | -48.9% |
| Q3 2021 | $303,000 | +47.1% | 24,110 | -4.9% | 0.13% | +56.5% |
| Q2 2021 | $206,000 | -21.7% | 25,361 | -10.9% | 0.08% | -23.4% |
| Q1 2021 | $263,000 | -2.6% | 28,463 | +1.8% | 0.11% | -0.9% |
| Q4 2020 | $270,000 | -13.5% | 27,963 | +11.3% | 0.11% | -31.7% |
| Q3 2020 | $312,000 | -15.9% | 25,129 | -12.0% | 0.16% | -6.8% |
| Q2 2020 | $371,000 | +157.6% | 28,554 | +101.6% | 0.18% | +198.3% |
| Q1 2020 | $144,000 | -43.3% | 14,166 | -12.8% | 0.06% | +40.5% |
| Q4 2019 | $254,000 | +21.5% | 16,245 | +30.2% | 0.04% | 0.0% |
| Q3 2019 | $209,000 | -28.4% | 12,473 | -5.3% | 0.04% | -32.3% |
| Q2 2019 | $292,000 | – | 13,168 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |